Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses
Norbert Pardi(University of Pennsylvania), Meagan McMahon(Seqirus (United States))
Cited by 83
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
|The Journal of Experimental Medicine|2018|517
Innate immune mechanisms of mRNA vaccines
|Immunity|2022|440
In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
|Nature Biotechnology|2021|375